Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Sarepta Therapeutics, Inc.

Pharmaceutical Preparations · Cambridge, MA, United States

  1. PrincipalsDouglas S IngramChief Executive OfficerIan Michael EstepanChief Operating OfficerLouise Rodino-KlapacPresident, R&D and Tech Opsand 6 more
  2. CompanySarepta Therapeutics, Inc.Cambridge, MA, United States
  3. Phone line+1 (617) 274-4000General business
Request a quotesarepta.com ↗

Sarepta Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker SRPT) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 9

Chief executive

Douglas S IngramChief Executive Officer
Louise Rodino-KlapacPresident, R&D and Tech Ops

Chair & board

Claude NicaiseDirector (Board)
M Kathleen BehrensDirector (Board)
Michael Andrew ChambersDirector (Board)
Stephen MayoDirector (Board)

Finance

Ryan Ho-Yan WongChief Financial Officer

Operations

Ian Michael EstepanChief Operating Officer

Legal

Cristin RothfussEVP, General Counsel

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Ryan Ho-Yan Wong — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Ian Michael Estepan — Chief Operating Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Louise Rodino-Klapac — President, R&D and Tech Ops

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Douglas S Ingram — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers